Cargando…

Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69)

Detalles Bibliográficos
Autores principales: Paz-Ares, Luis, Moecks, Joachim, Klughammer, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822634/
https://www.ncbi.nlm.nih.gov/pubmed/21362132
http://dx.doi.org/10.1111/j.1582-4934.2011.01295.x
_version_ 1782290436487905280
author Paz-Ares, Luis
Moecks, Joachim
Klughammer, Barbara
author_facet Paz-Ares, Luis
Moecks, Joachim
Klughammer, Barbara
author_sort Paz-Ares, Luis
collection PubMed
description
format Online
Article
Text
id pubmed-3822634
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-38226342015-04-06 Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69) Paz-Ares, Luis Moecks, Joachim Klughammer, Barbara J Cell Mol Med Letter to the Editor Blackwell Publishing Ltd 2011-05 2011-05-26 /pmc/articles/PMC3822634/ /pubmed/21362132 http://dx.doi.org/10.1111/j.1582-4934.2011.01295.x Text en © 2011 F. Hoffmann - La Roche Ltd. Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
spellingShingle Letter to the Editor
Paz-Ares, Luis
Moecks, Joachim
Klughammer, Barbara
Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69)
title Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69)
title_full Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69)
title_fullStr Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69)
title_full_unstemmed Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69)
title_short Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69)
title_sort reply to watkins and rukazenkov (j cell mol med 2010), re-letter of response to manuscript entitled ‘clinical outcomes in nsclc patients with egfr mutations: pooled analysis’ (paz-ares et al., j cell mol med. 2010; 14(1–2): 51–69)
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822634/
https://www.ncbi.nlm.nih.gov/pubmed/21362132
http://dx.doi.org/10.1111/j.1582-4934.2011.01295.x
work_keys_str_mv AT pazaresluis replytowatkinsandrukazenkovjcellmolmed2010reletterofresponsetomanuscriptentitledclinicaloutcomesinnsclcpatientswithegfrmutationspooledanalysispazaresetaljcellmolmed201014125169
AT moecksjoachim replytowatkinsandrukazenkovjcellmolmed2010reletterofresponsetomanuscriptentitledclinicaloutcomesinnsclcpatientswithegfrmutationspooledanalysispazaresetaljcellmolmed201014125169
AT klughammerbarbara replytowatkinsandrukazenkovjcellmolmed2010reletterofresponsetomanuscriptentitledclinicaloutcomesinnsclcpatientswithegfrmutationspooledanalysispazaresetaljcellmolmed201014125169